chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Dizziness; Upset stomach; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 2 patients. This is 1st of two reports. This consumer reported for a female patient (Mother i.e., is a friend of my mother's). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number were not reported), via unspecified route on Feb2021 as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 Immunization. The patient's medical history and concomitant medications were not reported. The patient experienced Fever, dizziness, upset stomach on an unspecified date. The patient did not received any treatment for the events. The clinical outcome of the events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021161215 same reporter/SD/AE, different patient
Chills early, then later in day and night.  Took advil for morning and tylenol towards evening and night.
1 day p/vax c/o itching arm; the next morning arm was hot, red, swollen & hard; from the elbow to the shoulder; called MD who recommended DPH & APAP for comfort; pt used APAP; swelling & itching dec by 19MAY95
Myopericarditis developed significant chest pain, sob on 5/6/2021.  hospitalized 5/7/2021.
Shortly after administering vaccine, I was informed by patient that he was experiencing burning at injection site. A red area approximately 3 inches in diameter and some swelling developed. Patient said burning seemed to peak, and then began to subside (as did redness and swelling). About 30 minutes after onset, pt. said he was feeling better and was able to leave.
a second full dose 3 days after the improper unsuccessful dos; didn't get his 2nd dose properly; needle popped out, and not sure if any medical product went in; did not get his 2nd dose properly; This spontaneous case was reported by a patient and describes the occurrence of MEDICATION ERROR ( didn't get his 2nd dose properly) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LEVOTHYROXINE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced MEDICATION ERROR ( didn't get his 2nd dose properly). At the time of the report, MEDICATION ERROR ( didn't get his 2nd dose properly) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: No specific follow-up information recorded.; Reporter's Comments: This report refers to a case of vaccine underdose and syringe connection issue for mRNA-1273, lot # 031A21A  with no associated AEs
Dizziness, Headache, SkinRash, Rash & HYPERtension
MISSED TO TAKE THE THIRD DOSE OF VIVOTIF; This spontaneous case report was received from a pharmacist (PVX2019-385) on 12-Feb-2018. The report describes a male consumer who "missed to take the third dose of Vivotif". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer took doses of Vivotif on Wednesday (06-Feb-2019) and Friday (08-Feb-2019). He missed to take her third dose of Vivotif and did not take any further dose.  The action taken with Vivotif with respect to the event "missed to take the third dose of Vivotif" was not applicable.  The clinical outcome of the event "missed to take the third dose of Vivotif" was unknown.  Company's Comment: The causality of the event "missed to take the third dose of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take the third dose of Vivotif" was considered as not applicable.
just itched; arm was really sore for 3-4 days; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (had the old shot).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm and pruritus. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the pruritus was unknown.   It was unknown if the reporter considered the pain in arm and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The reporter informed that if you had the old shingles shot, the shingles would worry you but not be too painful and her husband was just getting over them and that was his experience. The reporter had the old shot as well, but no shingles so she got the new shot right away, it was a two-dose shot, so she would have to get the second one within the six-month period.  The reporter informed that her arm was really sore for 3 to 4 days and after that it just itched. The follow up would not possible as no contact details were available.
Noticed two or three weeks after receiving the Pfizer Covid 19 Vaccine, muscles in nose are basically twitching, muscles in nose move out of nowhere; Noticed two or three weeks after receiving the Pfizer Covid 19 Vaccine, muscles in nose are basically twitching, muscles in nose move out of nowhere; Noticed two or three weeks after receiving the Pfizer Covid 19 Vaccine, muscles in nose are basically twitching, muscles in nose move out of nowhere; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22-year-old male patient received BNT162b2 (BNT162B2), on 02Mar2022 at 10:00 as dose 2, single (Lot number: FK9729) at the age of 22 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (ongoing), notes: Asthma is not acting up. Caller was born with Asthma. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose, Lot: FK9729, Time: 1000), administration date: Feb2022, for COVID-19 immunization. The following information was reported: MUSCLE TWITCHING (non-serious), DYSKINESIA (non-serious), NASAL DISCOMFORT (non-serious) all with onset Mar2022, outcome "not recovered" and all described as "Noticed two or three weeks after receiving the Pfizer Covid 19 Vaccine, muscles in nose are basically twitching, muscles in nose move out of nowhere".  Additional information: The  number was unknown. The patient did not received any other vaccine within 4 week to COVID vaccination. The caller does not have name, address, telephone number or email to provide. The caller has been to doctor in over 7 years.   No follow-up attempts are possible. No further information is expected
weakness; chills; head hurting; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), CHILLS (chills), HEADACHE (head hurting) and NAUSEA (nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ASTHENIA (weakness), CHILLS (chills), HEADACHE (head hurting) and NAUSEA (nausea). At the time of the report, ASTHENIA (weakness), CHILLS (chills), HEADACHE (head hurting) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: NNI. reporter declined to give email or fax and declined FU
Two days post vax, the pt developed a cough. On 6/3, she became irritable with crying, excessive sleepiness; followed by staring, irrational babbling, vomiting and began focal motor seizure involving her right arm and right side of face. The staring phase seizure lasted approximately 20 minutes. Brief apnea with cyanosis. Postictal for 1 to 2 hours. Duration of total neurological change was 5 hours. Returned to normal level of functioning.
Approximately 8  hours after receiving my first moderna vaccine, my right arm became very painful. Raising my shoulder above my head was difficult. Moving the shoulder at all, caused pain.  I developed a grape sized knot at the injection site with a red rash.  This lasted 3 days and suddenly went away.  With my 2nd vaccine, lot number 017B21A given on 4/12/21 at 3:55 pm,  about 8 hours later developed a sore arm.  the grape sized knot appeared, red rash. Itching.  The site was too sore to scratch.  I was able to move my arm more freely this time around.  The soreness lasted one week, the itching one week, the rash one week and the knot is still present, though smaller 8 days out.
Narrative:  PT WAS VACCINATED IN A TIMELY MANNER 12/30/20, 1/20/21 AND PROVIDED BOOSTER 10/7/21 OF PFIZER MRNA VACCINE. PT CAME TO ED WITH COMPLAINTS OF WEAKNESS AFTER FALLING. PATIENT TESTED POSITIVE FOR COVID. HE WAS ADMITTED FOR WEAKNESS. PATIENT WAS TREATED, RECOVERED , AND DISCHARGED AFTER SHORT HOSPITAL STAY.
A spontaneous report was received on 14JUL2016 from a consumer. An approximately 38 year old female reported experiencing a swollen arm, heart racing and felt sick following immunization with BIOTHRAX when she was approximately 26 years old. In DEC2003 she received the first dose of BIOTHRAX (lot # reported as FAV068). Additional vaccines were received on same date or around same date in preparation for deployment. Following vaccination the consumer reports she experienced a swollen arm, heart racing and felt sick. She was seen at Emergency Room where treatment with Benadryl was given. The initial symptoms were reported to be resolved. The consumer also reported experiencing several health issues over the years since vaccination, including Hashimoto's thyroiditis (diagnosed approximately 2005); Lupus (diagnosed approximately 2008); vasculitis in both legs (diagnosed approximately 2012-2013); fluid around heart (diagnosed approximately 2006); cyst on liver (diagnosed approximately 2014); and kidney stones (diagnosed approximately 2004). Upon review of lot FAV068 it is noted that this lot of BIOTHRAX vaccine was never produced.  Additional information has been requested.
This spontaneous report has been received from a physician via company representative referring to unspecified patients of unknown age. On unknown dates the patients were vaccinated with unspecified HPV vaccine (manufacturer unknown) (dose, frequency, route and lot# not reported) (cannot rule out GARDASIL or GARDASIL 9). The patients had other types of unspecified warts that were not genital warts prior to administering the HPV vaccine. The unspecified dermatologist stated that the warts that the patients had "went away" after vaccinating the patient with an HPV vaccine. The outcome of therapeutic response unexpected was unknown. It was unknown if the patient sought any medical attention. Additional information is not expected as there is no consent for follow up.
This spontaneous report was received from a Registered Nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On unspecified dates, the patient was vaccinated with improperly stored dose of GARDASIL (lot # J009788, expiration date 17-MAR-2016; lot# K007264, expiration date unknown (dose, indication and route of administration were not reported). Concomitant therapy was not provided. No adverse effect was reported. Follow up information has been received from reporting nurse during a phone call on 23-NOV-2015. The nurse stated that she would have to research the requested information (patient identifiers, lot number, expiry date and dates of vaccination) and she may fax them later, if the information becomes available. This is one of several cases received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 15 year old female who on 29-FEB-2008 was vaccinated with GARDASIL (lot number not specified).  Concomitant therapy included MENACTRA given in one arm and PEDIARIX given in the same arm as the GARDASIL.  The patient had a reaction in the arm the MENACTRA was given (unspecified if it was the right or left arm).  On 29-FEB-2008 the patient experienced uncontrolled spasms in fingers and tingling in fingers.  The reaction has now stopped getting worse and the physician feels the patient is recovering.  The physician feels that could be due to any of these vaccines although GARDASIL was not given in this arm.  The patient sought medical attention and is being treated with FLEXERIL and ATIVAN.  No other information is available.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 4/14/2008.  Additional follow up information indicated the vaccinations were done in Arizona.
Redness, swelling on injection site for approximately 1 week. Fever and body aches approximately 1 week.
Pt received Tdap @ 9:30 am on 6/10/09. At 12 00 pm on 6/11/09 pt developed nausea. Had to lie down for 15 hrs and fell asleep. Woke up 3am on 6/12/09 feeling better no fever. Just felt out of is a diabetic. Evening 6/11 blood glucose 231 took insulin 3 hrs later down to 69 then drank juice. That morning blood sugar was 120.
Dizziness, paleness, high fever, fine next day and then dizziness, paleness, high fever started again 11-12-2009 and patient missed school on 11-13-2009.  Recovery time Unknown at this time.
7/19--presently admitted 65y.o. female with past medical history oligodendroglioma s/p chemoradiation with residual right hemiparesis, dementia, cognitive impairment, nonverbal at baseline, hypertension, hypothyroidism, depression, anxiety presenting for altered mental status and fever. Patient is nonverbal at baseline, history obtained from available notes as well as her son at bedside. Discussed her care at length with him. She has been in skilled care facility since May. Family and staff found her difficult to awaken on 7/18. She was minimally responsive. Found to be febrile at that time. No other observed symptoms. At presentation, she tested positive for COVID-19.
2/10/2021: Woke up with a itchy red rash at the site of the injection 2/11/2021: Red rash has tuned into a large red swollen round mass that is warm to the touch.
Skin was pinched/bunched upon being administered. Irritation and pain was immediately felt. Swelling, redness, lack of mobility, and pain throughout entire arm has been felt since the injection. At 48 hours out, I developed pain at elbow joint, low-grade fever, and tingling in my pinky finger. I am now 60 hours out, and none of the injection site symptoms have subsided. It appears that it may have been an inadvertent subcutaneous injection, as well as possibly being too high up on my arm.
5 minutes after injection developed metallic taste in mouth follwed by limited ability to taste starting to resolve 4/4/21.
Nose bleeds, body aches, hair falling off of the exterior part of my lower legs, headaches.  All of the adverse events described started after the second Moderna dose, which was administered on 13 April 2021.
For dose 1 (01/15/2021), had lingering headache for 2-3 days post vaccination.   For dose 2 (02/12/2021), had body aches and soreness throughout the evening of 2/12 and almost all day on 2/13. Fatigue experienced during same time frame. Following the relief of fatigue and sores, experienced rash/hive-like spots on both arms and on back. Rash does not itch or hurt.
Left arm tenderness, erythema, rash, edema, body aches, joint pain. Treated: BACTIM DS BID x 10 days, Mupirocin 2% ointment.
Individual reports a "baseball" size swollen lymph node in left armpit.  Also reported a fever that resolved after tylenol.
During observation period after receiving vaccine, client became nauseous, short of breath, and itchy. Our staff moved patient to lay down on a mat, shortly after that pt was no longer oriented x2. Client quickly became oriented x3 after that but began complaining of intermittent chest pain. SP02 was 94%, HR 94-97, client still short of breath and diaphoretic. Gave Bendadryl around 5:15pm with resolution of itchiness. Patient rated chest pain as 10/10 specifically on right side and his back. Complained of metalic taste in mouth. Heart rate up to 114 and SP02 sitting around 96%. Ambulance arrived at 5:25pm and took pt to hospital.
Information has been received from a coordinator of health services concerning a second grader who may have been vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In February 2008,("over the last several weeks"), the patient developed chickenpox. The reporter did not know if the patient had been vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck); could not verify administration route and did not know if it had ever been introduced. At the time of the report the patient's status was unknown. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/16/2008.  Follow-up information received 21-APR-2008:  The coordinator of health services does not have specific patient information on any of the children.  Additional information is not expected.
Rash, itching, discharge at rash site; 4-5 days after administration, pain L and R shoulder and neck.
Have experienced dizziness when laying down or getting up and at times when turning head from side to side.
now have covid; now have covid; severe asthma; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 20211123000713 (RA).  An elderly patient received bnt162b2 (COVID-19 MANUFACTURER UNKNOWN),(Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE) (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "now have covid"; ASTHMA (non-serious), outcome "unknown", described as "severe asthma"; AGEUSIA (non-serious), ANOSMIA (non-serious), outcome "unknown" and all described as "cannot taste or smell anything". The lot number for bnt162b2 was not provided and will be requested during follow up.
6" x 5 1/2" red and patchy red area extending from slightly above injection site on LLT to knee level. Leg swollen 12 3/4 on Left compared to 12" on right.  C/o itching and pain. Apply cold compress.
really red.; It is itchy; rash but only in the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash but only in the injection site), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE ERYTHEMA (really red.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unkown) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE RASH (rash but only in the injection site) and PAIN IN EXTREMITY (Sore arm). On 28-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (It is itchy). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (really red.). At the time of the report, VACCINATION SITE RASH (rash but only in the injection site), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE ERYTHEMA (really red.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided   This case was linked to MOD-2021-036085, MOD-2021-036546, MOD-2021-036546 (Patient Link).
On 19JAN2023 COVID-19 Test- Positive, I had a headache, fatigue, runny nose and body aches.
Information has been received from a Nurse Practitioner (N.P.) concerning an approximately 28 day old (reported as a 4 week old) female patient who on 14-FEB-2011 was vaccinated orally with the first dose of ROTATEQ (lot # not reported). The nurse practitioner stated that this infant spat out an unknown amount of this dose. No adverse effect reported. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. This is an amended report. The reporting status was changed from do not send to periodic.
This spontaneous report as received from a physician via a company representative refers to a 2 year old male patient. On 24-JUL-2013 the patient was vaccinated with M-M-R II (lot number reported as H015824, expiration date unspecified; dose, route and site unknown). The patient presented to the office with a fever and roseola-type rash "about ten days later" approximately on 03-AUG-2013. The outcome of fever and roseola-type rash was reported as recovered/resolved (date unspecified). Additional information has been requested.
Phlebitis, UrticariaPruritus, GUM AND JAW PAIN 7 DAYS POST VACCINE. SMALL ULCERS IN MOUTH. TENDER SCALP. TENDER TINGLING SENSATION AROUND MOUTH AND LIPS. Narrative:
That evening there was pain at the site of the inj.  Pt. also experienced a feeling of "pins and needles" that went from the shoulder down below her elbow.  Redness appeared also starting at the shoulder to about 4 inches past inj. site.  No itching.  Next day pt. felt feverish, and the pins and needles sensation went down into her fingers.  About day 4, the tips of her fingers felt numb.  Pt. felt feverish for about 3 1/2 days, and also experienced night sweats, and fatigue.   Also the day after the inj. swelling started that progressed over the following days that went down past her elbow, and was a bright pink color.  The swelling was about 3" across.  Things started to improve on Monday, and symptoms had completely went away by the next day which was day 6.  The temp. never went 100 degrees, but pt. stayed on tylenol the whole time.  The reaction was reported to the nurse on July 14th.